Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Nov;10(3):26-30.
doi: 10.5704/MOJ.1611.013.

Role of Local Infiltration of Tranexamic Acid in Reducing Blood Loss in Peritrochanteric Fracture Surgery in the Elderly Population

S R Virani  1 , A A Dahapute  1 , I Panda  1 , S S Bava  1
Affiliations

Role of Local Infiltration of Tranexamic Acid in Reducing Blood Loss in Peritrochanteric Fracture Surgery in the Elderly Population

S R Virani et al. Malays Orthop J. 2016 Nov.

Abstract

Introduction: Peritrochanteric fractures are common injuries occurring in elderly patients. Surgeries for these fractures are associated with significant blood loss. Intravenous tranexamic acid has a proven track record in many orthopaedic surgeries including trauma, arthroplasty and spine surgeries. Objective: To study the effect of local subfascial and intramuscular infiltration of tranexamic acid in reducing blood loss and the requirement for blood transfusion in intertrochanteric fracture surgery. Study Design: Single centre prospective analytical study. Materials and Methods: One hundred and thirty seven patients above 65 years of age were included in the study, divided into two groups: the intervention group received subfascial and intramuscular infiltration of 2g tranexamic acid before wound closure and the control group of alternate patients did not receive any tranexamic acid infiltration. The postoperative drain output was recorded, as well as the haemoglobin level and the patients needing blood transfusion. Results and Conclusions: The preoperative and postoperative haemoglobin values were recorded. The mean preoperative haemoglobin was 10.9% and 10.8% (p=0.79) in the trial and control groups respectively. The mean postoperative haemoglobin was 9.5gm% and 9.2gm% (p=0.36) in the two groups. The total postoperative blood loss in the tranexamic acid group and the control group was 190.3ml and 204.3ml respectively (p=0.25). Ten patients (14.9%) in the intervention group and 12 patients (17.1%) in the control group required blood transfusion. We conclude that tranexamic acid does not play a significant role in reducing postoperative blood loss and blood transfusion when used locally in peritochanteric fracture surgery. However a larger double blinded study comparing various modalities of use of tranexamic acid is needed to conclusively establish its role.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Drop in haemoglobin in both trial and control groups postoperatively.
Fig. 2
Fig. 2
Postoperative blood loss (drain output) in control and trial groups on each of the postoperative days.
See this image and copyright information in PMC

References

    1. Metcalfe D, Salim A, Olufajo O, Gabbe B, Zogg C, Harris MB.et al.Hospital case volume and outcomes for proximal femoral fractures in the USA: an observational study BMJ Open. 20166(4) - PMC - PubMed
    1. Yu W, Zhang X, Wu R, Zhu X, Hu J, Xu Y, Yi J.et al.The visible and hidden blood loss of Asia proximal femoral nail anti-rotation and dynamic hip screw in the treatment of intertrochanteric fractures of elderly high- risk patients: a retrospective comparative study with a minimum 3 years of follow-up BMC Musculoskelet Disord. 201617269. - PMC - PubMed
    1. Zhang L, Su W, Zhao J. Risk factors of perioperative blood loss in elderly patients receiving proximal femur locking compression plate fixation for intertrochanteric fractures. Nan Fang Yi Ke Da Xue Xue Bao. 2015;35((12)):1797–801. - PubMed
    1. Echave M, Oyagüez I, Casado MA. Use of Floseal (R), a human gelatine-thrombin matrix sealant, in surgery: a systematic review. BMC Surg. 2014;14:111. - PMC - PubMed
    1. Astermark J, Rocino A, Von Depka M, Van Den Berg HM, Gringeri A, Mantovani LG.et alEHTSB: Current use of bypassing agents in Europe in the management of acute bleeds in patients with haemophilia and inhibitors Haemophilia. 20071338–45. - PubMed

LinkOut - more resources